Peter Geoffrey Welch
Director/Board Member at LKM Innovations Ltd.
Profile
Peter Geoffrey Welch is currently a Director at LKM Innovations Ltd., LumiraDx Investment Ltd., and Treisar Investments Ltd.
He was previously the Managing Director at Unipath Ltd.
and the Vice President-European Business Development at Alere, Inc.
Peter Geoffrey Welch active positions
Companies | Position | Start |
---|---|---|
LKM Innovations Ltd.
LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | Director/Board Member | 05/02/2015 |
LumiraDx Investment Ltd.
LumiraDx Investment Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Investment Ltd. is a British company that manufactures medical and dental instruments. The company is based in London, UK and was founded in 2016. | Director/Board Member | 04/07/2016 |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | Director/Board Member | 23/12/2015 |
Former positions of Peter Geoffrey Welch
Companies | Position | End |
---|---|---|
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Corporate Officer/Principal | - |
ALERE INC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Alere, Inc.
Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Health Technology |
LKM Innovations Ltd.
LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | Commercial Services |
LumiraDx Investment Ltd.
LumiraDx Investment Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Investment Ltd. is a British company that manufactures medical and dental instruments. The company is based in London, UK and was founded in 2016. | Health Technology |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | Finance |
- Stock Market
- Insiders
- Peter Geoffrey Welch